UBS Maintains Neutral on Calumet, Raises Price Target to $47
UBS analyst Manav Gupta maintains Calumet (NASDAQ:CLMT) with a Neutral and raises the price target from $26 to $47.
Read original at benzingaStocks · News reference
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
UBS analyst Manav Gupta maintains Calumet (NASDAQ:CLMT) with a Neutral and raises the price target from $26 to $47.
Read original at benzingaGoldman Sachs analyst Neil Mehta maintains Calumet (NASDAQ:CLMT) with a Neutral and raises the price target from $40 to $45.
Read original at benzingaTD Cowen analyst Jason Gabelman maintains Calumet (NASDAQ:CLMT) with a Hold and raises the price target from $34 to $40.
Read original at benzingaFiled: 2026-08-26 AccNo: 0001628280-26-059117 Size: 181 KB Item 8.01: Other Events
Read original at edgar